Tscan Therapeutics Inc
Biotechnology
Healthcare
TCRX
119 M shares
NASDAQ US
traded
31 Mar 2025
listed
no
open
1.29
52 week high
9.51
high
1.45
52 week low
1.35
previous Close
1.35
P/E ratio
market cap
163 M
div yield
0
net incoming
-29.89 M
5.60 %
net profit margin
-2849.09 %
3057.00 %
operating incoming
-32.62 M
4.37 %
net change in cash
-109.04 M
-207.28 %
cash on hand
133 M
-45.03 %
top